• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table C.14Model 1 base case resuts: cost-effectiveness by age and sex

MenWomen
Age 20The ‘ACR strategy’ dominates the ‘no testing strategy’The ‘ACR strategy’ dominates the ‘no testing strategy’
Age 40The ‘ACR strategy’ dominates the ‘no testing strategy’The ‘ACR strategy’ dominates the ‘no testing strategy’
Age 60The ‘ACR strategy’ is cost-effectiveThe ‘ACR strategy’ is cost-effective
Age 80The ‘ACR strategy’ is cost-effectiveThe ‘ACR strategy’ is cost-effective
*

Cost-effectiveness threshold=£20,000 per QALY gained

From: Appendix C, Health economic model – Cost effectiveness of CKD case finding among people at high risk

Cover of Chronic Kidney Disease
Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care.
NICE Clinical Guidelines, No. 73.
National Collaborating Centre for Chronic Conditions (UK).
Copyright © 2008, Royal College of Physicians of London.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.